The global Atherosclerosis Drugs market is projected to grow from US$ 40180 million in 2024 to US$ 43670 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.4% during the forecast period.

Atherosclerosis Drugs Market

Market Analysis and Insights: Global Atherosclerosis Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Atherosclerosis Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Atherosclerosis Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Atherosclerosis Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atherosclerosis Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Atherosclerosis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Atherosclerosis Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Atherosclerosis Drugs Market Report

Report Metric	Details
Report Name	Atherosclerosis Drugs Market
Accounted market size in 2024	US$ 40180 million
Forecasted market size in 2030	US$ 43670 million
CAGR	1.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Corticosteroids PDE4 Inhibitors Biologics Skin Barrier Emollients CNI Immunosuppressants Others
Segment by Application	Hospital Clinic Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Sanofi, F. Hoffmann-L a Roche, Bayer, Novartis, Merck, Janssen Pharmaceutical, Amgen, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Atherosclerosis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Atherosclerosis Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atherosclerosis Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Atherosclerosis Drugs Market growing?

Ans: The Atherosclerosis Drugs Market witnessing a CAGR of 1.4 during the forecast period 2025-2030.

What is the Atherosclerosis Drugs Market size in 2030?

Ans: The Atherosclerosis Drugs Market size in 2030 will be US$ 43670 million.

Who are the main players in the Atherosclerosis Drugs Market report?

Ans: The main players in the Atherosclerosis Drugs Market are GlaxoSmithKline, Sanofi, F. Hoffmann-L a Roche, Bayer, Novartis, Merck, Janssen Pharmaceutical, Amgen, Pfizer

What are the Application segmentation covered in the Atherosclerosis Drugs Market report?

Ans: The Applications covered in the Atherosclerosis Drugs Market report are Hospital, Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Atherosclerosis Drugs Market report?

Ans: The Types covered in the Atherosclerosis Drugs Market report are Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Atherosclerosis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Corticosteroids

1.2.3 PDE4 Inhibitors

1.2.4 Biologics

1.2.5 Skin Barrier Emollients

1.2.6 CNI Immunosuppressants

1.2.7 Others

1.3 Market by Application

1.3.1 Global Atherosclerosis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Retail Pharmacies

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Atherosclerosis Drugs Market Perspective (2019-2030)

2.2 Global Atherosclerosis Drugs Growth Trends by Region

2.2.1 Atherosclerosis Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Atherosclerosis Drugs Historic Market Size by Region (2019-2024)

2.2.3 Atherosclerosis Drugs Forecasted Market Size by Region (2025-2030)

2.3 Atherosclerosis Drugs Market Dynamics

2.3.1 Atherosclerosis Drugs Industry Trends

2.3.2 Atherosclerosis Drugs Market Drivers

2.3.3 Atherosclerosis Drugs Market Challenges

2.3.4 Atherosclerosis Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Atherosclerosis Drugs by Players

3.1.1 Global Atherosclerosis Drugs Revenue by Players (2019-2024)

3.1.2 Global Atherosclerosis Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Atherosclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Atherosclerosis Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Atherosclerosis Drugs Market Concentration Ratio

3.4.1 Global Atherosclerosis Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Atherosclerosis Drugs Revenue in 2023

3.5 Global Key Players of Atherosclerosis Drugs Head office and Area Served

3.6 Global Key Players of Atherosclerosis Drugs, Product and Application

3.7 Global Key Players of Atherosclerosis Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Atherosclerosis Drugs Breakdown Data by Type

4.1 Global Atherosclerosis Drugs Historic Market Size by Type (2019-2024)

4.2 Global Atherosclerosis Drugs Forecasted Market Size by Type (2025-2030)

5 Atherosclerosis Drugs Breakdown Data by Application

5.1 Global Atherosclerosis Drugs Historic Market Size by Application (2019-2024)

5.2 Global Atherosclerosis Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Atherosclerosis Drugs Market Size (2019-2030)

6.2 North America Atherosclerosis Drugs Market Size by Type

6.2.1 North America Atherosclerosis Drugs Market Size by Type (2019-2024)

6.2.2 North America Atherosclerosis Drugs Market Size by Type (2025-2030)

6.2.3 North America Atherosclerosis Drugs Market Share by Type (2019-2030)

6.3 North America Atherosclerosis Drugs Market Size by Application

6.3.1 North America Atherosclerosis Drugs Market Size by Application (2019-2024)

6.3.2 North America Atherosclerosis Drugs Market Size by Application (2025-2030)

6.3.3 North America Atherosclerosis Drugs Market Share by Application (2019-2030)

6.4 North America Atherosclerosis Drugs Market Size by Country

6.4.1 North America Atherosclerosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Atherosclerosis Drugs Market Size by Country (2019-2024)

6.4.3 North America Atherosclerosis Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Atherosclerosis Drugs Market Size (2019-2030)

7.2 Europe Atherosclerosis Drugs Market Size by Type

7.2.1 Europe Atherosclerosis Drugs Market Size by Type (2019-2024)

7.2.2 Europe Atherosclerosis Drugs Market Size by Type (2025-2030)

7.2.3 Europe Atherosclerosis Drugs Market Share by Type (2019-2030)

7.3 Europe Atherosclerosis Drugs Market Size by Application

7.3.1 Europe Atherosclerosis Drugs Market Size by Application (2019-2024)

7.3.2 Europe Atherosclerosis Drugs Market Size by Application (2025-2030)

7.3.3 Europe Atherosclerosis Drugs Market Share by Application (2019-2030)

7.4 Europe Atherosclerosis Drugs Market Size by Country

7.4.1 Europe Atherosclerosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Atherosclerosis Drugs Market Size by Country (2019-2024)

7.4.3 Europe Atherosclerosis Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Atherosclerosis Drugs Market Size (2019-2030)

8.2 China Atherosclerosis Drugs Market Size by Type

8.2.1 China Atherosclerosis Drugs Market Size by Type (2019-2024)

8.2.2 China Atherosclerosis Drugs Market Size by Type (2025-2030)

8.2.3 China Atherosclerosis Drugs Market Share by Type (2019-2030)

8.3 China Atherosclerosis Drugs Market Size by Application

8.3.1 China Atherosclerosis Drugs Market Size by Application (2019-2024)

8.3.2 China Atherosclerosis Drugs Market Size by Application (2025-2030)

8.3.3 China Atherosclerosis Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Atherosclerosis Drugs Market Size (2019-2030)

9.2 Asia Atherosclerosis Drugs Market Size by Type

9.2.1 Asia Atherosclerosis Drugs Market Size by Type (2019-2024)

9.2.2 Asia Atherosclerosis Drugs Market Size by Type (2025-2030)

9.2.3 Asia Atherosclerosis Drugs Market Share by Type (2019-2030)

9.3 Asia Atherosclerosis Drugs Market Size by Application

9.3.1 Asia Atherosclerosis Drugs Market Size by Application (2019-2024)

9.3.2 Asia Atherosclerosis Drugs Market Size by Application (2025-2030)

9.3.3 Asia Atherosclerosis Drugs Market Share by Application (2019-2030)

9.4 Asia Atherosclerosis Drugs Market Size by Region

9.4.1 Asia Atherosclerosis Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Atherosclerosis Drugs Market Size by Region (2019-2024)

9.4.3 Asia Atherosclerosis Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Atherosclerosis Drugs Introduction

11.1.4 GlaxoSmithKline Revenue in Atherosclerosis Drugs Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Developments

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Atherosclerosis Drugs Introduction

11.2.4 Sanofi Revenue in Atherosclerosis Drugs Business (2019-2024)

11.2.5 Sanofi Recent Developments

11.3 F. Hoffmann-L a Roche

11.3.1 F. Hoffmann-L a Roche Company Details

11.3.2 F. Hoffmann-L a Roche Business Overview

11.3.3 F. Hoffmann-L a Roche Atherosclerosis Drugs Introduction

11.3.4 F. Hoffmann-L a Roche Revenue in Atherosclerosis Drugs Business (2019-2024)

11.3.5 F. Hoffmann-L a Roche Recent Developments

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Atherosclerosis Drugs Introduction

11.4.4 Bayer Revenue in Atherosclerosis Drugs Business (2019-2024)

11.4.5 Bayer Recent Developments

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Atherosclerosis Drugs Introduction

11.5.4 Novartis Revenue in Atherosclerosis Drugs Business (2019-2024)

11.5.5 Novartis Recent Developments

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Atherosclerosis Drugs Introduction

11.6.4 Merck Revenue in Atherosclerosis Drugs Business (2019-2024)

11.6.5 Merck Recent Developments

11.7 Janssen Pharmaceutical

11.7.1 Janssen Pharmaceutical Company Details

11.7.2 Janssen Pharmaceutical Business Overview

11.7.3 Janssen Pharmaceutical Atherosclerosis Drugs Introduction

11.7.4 Janssen Pharmaceutical Revenue in Atherosclerosis Drugs Business (2019-2024)

11.7.5 Janssen Pharmaceutical Recent Developments

11.8 Amgen

11.8.1 Amgen Company Details

11.8.2 Amgen Business Overview

11.8.3 Amgen Atherosclerosis Drugs Introduction

11.8.4 Amgen Revenue in Atherosclerosis Drugs Business (2019-2024)

11.8.5 Amgen Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Atherosclerosis Drugs Introduction

11.9.4 Pfizer Revenue in Atherosclerosis Drugs Business (2019-2024)

11.9.5 Pfizer Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sanofi

F. Hoffmann-L a Roche

Bayer

Novartis

Merck

Janssen Pharmaceutical

Amgen Inc

Pfizer Inc

GlaxoSmithKline PLC

List of Tables

Table 1. Global Atherosclerosis Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Corticosteroids

Table 3. Key Players of PDE4 Inhibitors

Table 4. Key Players of Biologics

Table 5. Key Players of Skin Barrier Emollients

Table 6. Key Players of CNI Immunosuppressants

Table 7. Key Players of Others

Table 8. Global Atherosclerosis Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Atherosclerosis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Atherosclerosis Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Atherosclerosis Drugs Market Share by Region (2019-2024)

Table 12. Global Atherosclerosis Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Atherosclerosis Drugs Market Share by Region (2025-2030)

Table 14. Atherosclerosis Drugs Market Trends

Table 15. Atherosclerosis Drugs Market Drivers

Table 16. Atherosclerosis Drugs Market Challenges

Table 17. Atherosclerosis Drugs Market Restraints

Table 18. Global Atherosclerosis Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Atherosclerosis Drugs Revenue Share by Players (2019-2024)

Table 20. Global Top Atherosclerosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atherosclerosis Drugs as of 2023)

Table 21. Global Atherosclerosis Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Atherosclerosis Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Atherosclerosis Drugs, Headquarters and Area Served

Table 24. Global Key Players of Atherosclerosis Drugs, Product and Application

Table 25. Global Key Players of Atherosclerosis Drugs, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Atherosclerosis Drugs Revenue Market Share by Type (2019-2024)

Table 29. Global Atherosclerosis Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Atherosclerosis Drugs Revenue Market Share by Type (2025-2030)

Table 31. Global Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Atherosclerosis Drugs Revenue Share by Application (2019-2024)

Table 33. Global Atherosclerosis Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Atherosclerosis Drugs Revenue Share by Application (2025-2030)

Table 35. North America Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Atherosclerosis Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Atherosclerosis Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Atherosclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Atherosclerosis Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Atherosclerosis Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Atherosclerosis Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Atherosclerosis Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Atherosclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Atherosclerosis Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Atherosclerosis Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Atherosclerosis Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Atherosclerosis Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Atherosclerosis Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Atherosclerosis Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Atherosclerosis Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Atherosclerosis Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Atherosclerosis Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Atherosclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 67. GlaxoSmithKline Company Details

Table 68. GlaxoSmithKline Business Overview

Table 69. GlaxoSmithKline Atherosclerosis Drugs Product

Table 70. GlaxoSmithKline Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 71. GlaxoSmithKline Recent Developments

Table 72. Sanofi Company Details

Table 73. Sanofi Business Overview

Table 74. Sanofi Atherosclerosis Drugs Product

Table 75. Sanofi Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 76. Sanofi Recent Developments

Table 77. F. Hoffmann-L a Roche Company Details

Table 78. F. Hoffmann-L a Roche Business Overview

Table 79. F. Hoffmann-L a Roche Atherosclerosis Drugs Product

Table 80. F. Hoffmann-L a Roche Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 81. F. Hoffmann-L a Roche Recent Developments

Table 82. Bayer Company Details

Table 83. Bayer Business Overview

Table 84. Bayer Atherosclerosis Drugs Product

Table 85. Bayer Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 86. Bayer Recent Developments

Table 87. Novartis Company Details

Table 88. Novartis Business Overview

Table 89. Novartis Atherosclerosis Drugs Product

Table 90. Novartis Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 91. Novartis Recent Developments

Table 92. Merck Company Details

Table 93. Merck Business Overview

Table 94. Merck Atherosclerosis Drugs Product

Table 95. Merck Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 96. Merck Recent Developments

Table 97. Janssen Pharmaceutical Company Details

Table 98. Janssen Pharmaceutical Business Overview

Table 99. Janssen Pharmaceutical Atherosclerosis Drugs Product

Table 100. Janssen Pharmaceutical Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 101. Janssen Pharmaceutical Recent Developments

Table 102. Amgen Company Details

Table 103. Amgen Business Overview

Table 104. Amgen Atherosclerosis Drugs Product

Table 105. Amgen Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 106. Amgen Recent Developments

Table 107. Pfizer Company Details

Table 108. Pfizer Business Overview

Table 109. Pfizer Atherosclerosis Drugs Product

Table 110. Pfizer Revenue in Atherosclerosis Drugs Business (2019-2024) & (US$ Million)

Table 111. Pfizer Recent Developments

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Atherosclerosis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Atherosclerosis Drugs Market Share by Type: 2023 VS 2030

Figure 3. Corticosteroids Features

Figure 4. PDE4 Inhibitors Features

Figure 5. Biologics Features

Figure 6. Skin Barrier Emollients Features

Figure 7. CNI Immunosuppressants Features

Figure 8. Others Features

Figure 9. Global Atherosclerosis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Atherosclerosis Drugs Market Share by Application: 2023 VS 2030

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Retail Pharmacies Case Studies

Figure 14. Other Case Studies

Figure 15. Atherosclerosis Drugs Report Years Considered

Figure 16. Global Atherosclerosis Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Atherosclerosis Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Atherosclerosis Drugs Market Share by Region: 2023 VS 2030

Figure 19. Global Atherosclerosis Drugs Market Share by Players in 2023

Figure 20. Global Top Atherosclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atherosclerosis Drugs as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Atherosclerosis Drugs Revenue in 2023

Figure 22. North America Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Atherosclerosis Drugs Market Share by Type (2019-2030)

Figure 24. North America Atherosclerosis Drugs Market Share by Application (2019-2030)

Figure 25. North America Atherosclerosis Drugs Market Share by Country (2019-2030)

Figure 26. United States Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Atherosclerosis Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Atherosclerosis Drugs Market Share by Type (2019-2030)

Figure 30. Europe Atherosclerosis Drugs Market Share by Application (2019-2030)

Figure 31. Europe Atherosclerosis Drugs Market Share by Country (2019-2030)

Figure 32. Germany Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Atherosclerosis Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Atherosclerosis Drugs Market Share by Type (2019-2030)

Figure 40. China Atherosclerosis Drugs Market Share by Application (2019-2030)

Figure 41. Asia Atherosclerosis Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Atherosclerosis Drugs Market Share by Type (2019-2030)

Figure 43. Asia Atherosclerosis Drugs Market Share by Application (2019-2030)

Figure 44. Asia Atherosclerosis Drugs Market Share by Region (2019-2030)

Figure 45. Japan Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Atherosclerosis Drugs Market Share by Country (2019-2030)

Figure 55. Brazil Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Atherosclerosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 63. F. Hoffmann-L a Roche Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 64. Bayer Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 65. Novartis Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 67. Janssen Pharmaceutical Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 68. Amgen Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 69. Pfizer Revenue Growth Rate in Atherosclerosis Drugs Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Gamma Linolenic Acid (GLA) Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-19F10003

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Vascular Injury Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-30W5749

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Orthostatic Hypotension Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8Y6145

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Intracardiac Echocardiography Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-29W808

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions